Stem Cell Agency Evaluation Subcommittee Meeting April 19, 2011

Stem Cell Agency Evaluation Subcommittee Meeting
MEETING NOTICE AND AGENDA

REGULAR TELECONFERENCE MEETING
EVALUATION SUBCOMMITTEE
OF THE INDEPENDENT CITIZENS OVERSIGHT COMMITTEE
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE

Organized Pursuant to the
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

Date: Tuesday, April 19, 2011
Time: 4:00- 5:00 PM

Locations:

CIRM
210 King Street
San Francisco, CA 94107

8170 Laguna Blvd., #215
Elk Grove, CA 95758

The Sherry Lansing Foundation
2121 Avenue of the Stars, Suite 2020
Los Angeles, CA 90067

Klein Financial Corporation
550 California Avenue, Suite 330
Palo Alto, CA 94306

Onyx Pharmaceuticals, Inc.
2100 Powell Street
Emeryville, CA 94608

ValleyCare Health System
5575 West Las Positas Blvd.
Suite 300
Pleasanton, CA 94588

San Francisco City Attorney's Office
San Francisco International Airport
International Terminal, 5th Floor
San Francisco, CA 94128 

Open Session

1. Call to Order.

2. Roll Call.

Closed Session
3. Discussion of Personnel [Discussion of potential candidates for Chair] (Government Code section 11126, subdivision (a); Health & Safety Code section 125290.30(f) (3) (D)).

Open Session
4. Public Comment.

5. Adjournment.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizen’s Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizen’s Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.govStem Cell Agency Evaluation Subcommittee Meeting